The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases
Authors:
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapyBMC Cancer, 2014
- Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trialThe Lancet Oncology, 2013
- Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)Annals of Surgery, 2012
- Regional Chemotherapy: A Focus on Hepatic Artery Infusion for Colorectal Cancer Liver MetastasesSurgical Oncology Clinics of North America, 2008
- Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines CureJournal of Clinical Oncology, 2007
- Epidemiology and Management of Liver Metastases From Colorectal CancerAnnals of Surgery, 2006
- Technical Complications and Durability of Hepatic Artery Infusion Pumps for Unresectable Colorectal Liver Metastases: An Institutional Experience of 544 Consecutive CasesJournal of the American College of Surgeons, 2005
- Hepatic Arterial Infusion after Liver ResectionNew England Journal of Medicine, 2005
- Improvement in Perioperative Outcome After Hepatic ResectionAnnals of Surgery, 2002
- Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal CancerNew England Journal of Medicine, 1999